Thermopylae Holdings Ltd., 10% Owner at AbCellera Biologics Inc. (ABCL), bought 687,262 shares at $2.16 ($1.5M) on 2025-03-11, disclosed to the SEC on 2025-03-11.
Open-market purchase of $1.5M ABCL by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.16 | 343,631 | $742K | 50.0% |
| 2 | $2.16 | 343,631 | $742K | 50.0% |
| Total | $2.16 avg | 687,262 | $1.5M | 100% |
| Filing → |
| ABCL | BUY | 2024-08-29 | $1.5M | — | Filing → |
| ABCL | BUY | 2023-05-26 | $2.0M | — | Filing → |
| ABCL | BUY | 2022-12-20 | $1.7M | — | Filing → |